Conference at the Weizmann institute of Science

On April 7th 2019, Dr. Clément Thomas, leader of the Cytoskeleton and Cancer Progression group at LIH, was invited to give a presentation at the workshop "NK cells in cancer therapy: the next breakthrough" held at the Weizmann Institute of Science (Rehovot, Israel).
Dr. Thomas described how targeting the actin cytoskeleton could restore an effective anti-tumor immune response.

undefined undefined